Dr. Andrew Matsumoto, MD

Dr. Matsumoto practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Matsumoto's NPI, 1235661380, was assigned on March 29, 2017. Dr. Matsumoto holds New Mexico license MD2022-0400.

Dr. Matsumoto's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Matsumoto's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Matsumoto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matsumoto practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Matsumoto's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Matsumoto is licensed in New Mexico.

CMS data shows 1,092 Medicare services from Dr. Matsumoto across 18 procedure codes in 2024, for 332 Medicare patients. Medicare paid $106,060 for them. Every service was in an office.

CMS counts 332 Medicare patients who saw Dr. Matsumoto in 2024. The largest group is 65 to 74, with 134 patients. 66% of them have high blood pressure, and 59% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Matsumoto's median patient age at 74, with 43% women.

In 2024, Dr. Matsumoto wrote 307 Medicare Part D claims for 177 patients. 95% of them were for generic drugs. CMS names the drug for 226 of them, across 7 drugs with 11 or more claims each, at $2,050 in total drug cost. In 2023, CMS named 234 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Matsumoto for performance year 2024, reported as part of a group. Dr. Matsumoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of melanoma (skin cancer) excision by Dr. Matsumoto, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Matsumoto, published from 2020 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Mohs Surgery, Skin Neoplasms and Plastic Surgery Procedures. Dr. Matsumoto has published most often in Dermatol Surg. Dr. Matsumoto's most frequent co-authors are Rajiv I. Nijhawan, MD, Divya Srivastava, MD and Kevin Yang Shi.

CMS Open Payments shows 1 general payment to Dr. Matsumoto from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Kerecis Limited paid the most, $18.